Abstract
INTRODUCTION
Despite substantial improvement in survival and outcomes, elective total aortic arch surgery remains challenging and is associated with significant morbidity and mortality [1] [2] [3] . The use of thoracic endovascular aortic repair (TEVAR) in the transverse arch is still limited due to a lack of adequate proximal landing zones (LZs) and suitable aortic stent grafts, which safely match that of the arch's anatomy [4] [5] [6] . On the other hand, the use of hybrid techniques, such as the frozen elephant trunk (FET), is increasing, especially in extensive arch disease [7] [8] [9] .
Although aortic surgery has been routinely performed for decades, the true incidence of aortic events (AEs) and reoperations (REDO) following elective total aortic arch replacement remains unknown. Therefore, the aim of this analysis was to estimate, on the basis of mid-term follow-up data after 1232 elective arch replacements, the incidence of AEs, surgical strategies and postoperative outcomes after REDO.
MATERIALS AND METHODS
As previously reported [1] , the perioperative data of 1232 patients undergoing elective surgery for chronic aortic arch disease with at least 1 circular aortic anastomosis at 11 European aortic centres between January 2004 and December 2013 were retrospectively analysed (Supplementary Material, Table S1 ). Emergency (e.g. acute Type A aortic dissection) or unscheduled surgery (e.g. iatrogenic aortic injury) and hemiarch repairs were excluded from the primary analysis. The extent of elective arch repair was defined as partial, subtotal or total with regard to the reimplantation of 1, 2 or 3 supra-aortic arteries.
Incidence of aortic events
One hundred fifty-five (12.6%) patients with an AE during a median follow-up time of 48.7 [interquartile range (IQR) 23.7-81.9] months were identified and included in this study for further analysis. The median time interval between primary aortic arch surgery and occurrence of an AE was 11.3 (IQR 4.2-38.4) months. The median age at the time of AE and/or REDO was 64.9 (IQR 53.8-70.4) years, and 103 (66.5%) patients were men. Total arch replacement with reimplantation of all 3 supra-aortic branches was performed primarily in 149 (96.1%) cases including 41 (26.4%) with conventional elephant trunk (ET) and 79 (51%) with FET procedures, whereas 5 (3.2%) patients had had a subtotal and 1 patient (0.6%) had a partial arch replacement. Additional ascending aortic replacement during primary arch surgery was performed in supracoronary fashion (n = 87; 56.1%) or in conjunction with aortic root surgery in 43 (27.7%) patients. Table 1 lists the details of primary open arch surgery for the study cohort at the time of AE.
Definitions and statistical analysis
The ethics committee of the Cardiovascular Clinic Bad Neustadt granted approval for this study. The principal investigators of each particular clinic (Supplementary Material, Table S1 ) confirmed the validation of their respective data set, especially that all consecutive patients who underwent arch surgery according to the study definition had been included.
The methodology of data acquisition for the initial study group has been reported previously [1] . In brief, the patient data were retrospectively reviewed in the absence of prospectively collected data (depending on the respective centre). Follow-up of patients who were not included in a routine institutional surveillance programme was conducted via a telephone interview with patients and/or their respective physicians. The following variables were updated or added to the existing data set with regard to AE (with or without REDO): date and location of AE, reoperation date and treated aortic segment as well as survival (early and late) and neurological morbidity (permanent) postoperatively. Follow-up time comprised the time interval between the primary aortic arch surgery and the last patient contact or death of all patients, independently of occurring AEs. Patient deaths were not excluded.
AEs were defined as any aortic complication and/or aortic reoperation/reintervention following primary aortic arch repair. Aortic diameter progression, as a continuous process, was defined as an AE at the time when a need for surgical or endovascular treatment was evident (as indicated by the treating surgeon). The data analysis was performed according to the statistical and data reporting guidelines of the European Journal of Cardio-Thoracic Surgery [10] .
Categorical variables were reported using the number and percentage of occurrences. Continuous variables were expressed as median and IQR (25th-75th percentile) or mean ± standard deviation. The impact of the available variables on the in-hospital mortality was analysed using univariate and multivariate regression analyses. Binary logistic regression model was built using variables with a P-value of <0.1 from univariate analysis. A P-value of <0.05 was considered statistically significant. Actuarial survival was estimated by the Kaplan-Meier method. The statistical analysis was performed with the SPSS statistical software package (version 23.0; IBM, Ehningen, Germany).
RESULTS
The types of AE, their aortic localization and the treatment are presented in Table 2 . The most frequent type of AE was aortic diameter progression in 97 (62.6%) patients after a median of 12.5 (IQR 5.5-42.5) months-including patients without ET, with conventional ET and FET in 14 (14.4%), 29 (29.9%) and 54 (55.7%) cases, respectively. Comparison of both ET techniques revealed a significantly higher incidence of aortic diameter progression in patients with primary FET than conventional ET (35.2% vs 17.0%; P = 0.0001). The occurrence of a false aneurysm was less frequent (n = 6; 3.8%) with a late onset after arch surgery (median 41 months, IQR 37.0-80.0). In comparison, infection (n = 4; 3%) was found to be the earliest complication of the cohort with a median time-to-occurrence of 5.3 (IQR 1.1-12.4) months. Endoleak (n = 17; 11%) occurred at a median time frame of 6.8 (IQR 2.9-34.6) months. Acute life-threatening AE by means of 'rupture' and 'dissection', including 2 Type A and 3 Type B aortic dissections, occurred after a median time interval of 18.4 (IQR 6.5-31.5) and 48.6 (IQR 0-78.9) months, respectively. The median time interval between primary aortic arch surgery and occurrence of any AE was 11.3 (IQR 4.2-38.4) months.
The recorded AEs were distributed in the following locations: ascending aorta/arch, descending and abdominal aorta in 9.0% (n = 14), 79.4% (n = 123) and 10.3% (n = 16), respectively. Two (1.3%) patients had died in different peripheral hospitals due to acute aortic rupture. However, no further information, other than the plain cause of death (aortic rupture), regarding the exact aortic location could be obtained retrospectively.
In 133 patients suffering an AE, either an open or an endovascular REDO was performed, whereas 22 (14.1%) patients were either deemed inoperable or died prior to any intervention ( Table 2) .
Of note, 9 of the 133 patients required repeated treatment during follow-up time by means of 2 (n = 8, 6%) or 3 (n = 1, 0.8%) REDO procedures.
Surgical strategies
Open REDO was performed in 58 (43.6%) patients. The median interval between elective arch repair and open REDO was 13.9 (IQR 5.9-35.9) months. Proximal open repair of the ascending aorta or aortic arch was required in only 9 (6.8%) patients, whereas 49 (36.8%) patients underwent open surgical repair of the distal aorta, including the descending and abdominal aorta in 42 (31.6%) and 7 (5.3%) cases, respectively. Endovascular REDO of the thoracic or abdominal aorta was performed after a median time period of 9.2 (IQR 3.8-41.4) months. TEVAR was the primarily performed technique in 70 (52.6%) patients, whereas an abdominal endografting was performed in only 5 (3.2%) patients for diameter progression of abdominal aortic aneurysms (Table 2) .
Outcomes after reoperation
Median follow-up times for the entire AE cohort (n = 155) and for the REDO subcohort (n = 133) were 48.7 (IQR 23.7-81.9) months and 51.8 (IQR 29.8-83.9) months, respectively. The intraoperative mortality in the REDO subcohort was 7.5% (n = 10) with 6 (4.5%) intraoperative deaths during open surgery and 4 (3.0%) fatal endovascular reinterventions (P = 0.3309). Overall in-hospital mortality (including 10 intraoperative deaths) was 17.3% (n = 23). New (permanent) postoperative neurological complications comprised paraplegia (n = 8; 6.0%) and stroke (n = 2; 1.5%). Paraplegia was more frequent after open (n = 5) than after endovascular (n = 3) procedures (8.6% vs 4.0%; P = 0.2951) with an incidence after descending (n = 7) and abdominal (n = 1) aortic REDO of 6.2% and 12.5% (P = 0.4341), respectively. The respective 1-, 3-and 5-year survival rates after REDO were 81.2%, 79.0% and 76.7% (Fig. 1, Table 3 ).
Comparison of the survivals after open surgery of the proximal aorta (ascending aorta/arch) and descending aorta showed no significant differences (log rank, P = 0.613) (Fig. 2) . However, comparison of REDO for descending aortic pathology showed a trend toward better survival at 5 years after TEVAR versus open surgery: 77.2% vs 69.1% (log rank, P = 0.059) (Fig. 3) .
Univariate analysis identified the AE rupture (P < 0.001) and AE diameter progression (P = 0.006), older age at REDO (mean 61.3 ± 12.3 vs 70.1 ± 6.6 years; P = 0.002) and the primary surgical strategies 'FET' (P = 0.021) and 'no elephant trunk' (P = 0.029) as predictors of increased in-hospital mortality. However, multivariate analysis identified older age at REDO (P = 0.008) as the only independent risk factor for in-hospital mortality (Table 4 ; Supplementary Material, Table S2 ).
Causes of death for the entire study cohort (n = 155) were noted as aortic (18.6%), cardiac (3.8%), non-cardiac (5.1%), neurological (0.6%), sudden/unknown (2.6%) and other (0.6%) (Supplementary Material, Table S3 ). However, aortic-related deaths occurred in 14 (63.6%) of the 22 non-REDO patients.
DISCUSSION
Open surgery is still considered the gold standard for definite treatment of aortic arch pathologies with well-documented postoperative results worldwide [1, 3, 11, 12] . However, little is known about AEs after elective arch replacements and subsequent therapeutic strategies. As shown in the current analysis, most indications for REDO typically arise from the descending thoracic aorta rather than from the aortic arch or the ascending aorta. Despite being less frequently present and not directly related to proximal aortic arch repair in the study group, abdominal AEs can also develop over time and, if not diagnosed in time, may result in fatal outcomes (e.g. aortic rupture). This stresses the need for routine surveillance programmes after proximal aortic surgery-using advanced imaging techniques and interdisciplinary teams-to detect indications for REDO of the non-treated aortic segments at an early stage [13] .
Of the 1232 electively operated aortic arch repairs between 2003 and 2013 [1] , 155 (12.6%) patients experienced an AE during the median follow-up period of 48.7 months. Reoperation of the proximal aorta by means of ascending aortic REDO was very low and occurred in only 0.7% of the initial study cohort. This result confirms that elective open surgery of the arch, accompanied by surgical treatment of aortic valve and/or root, provides a very durable result for the proximal part of the aorta. In contrast, postoperative AEs frequently involve the distal aortic arch and the adjacent descending aorta, and often need to be resolved by several reinterventions. At the descending aortic level, 112 (84.2%) of 133 REDO patients underwent either open (n = 42, 31.6%) or endovascular (n = 70, 52.6%) surgery due to an AE. The most frequent AE in the study group (n = 155) was aneurysmal diameter progression in the descending aortic segment (n = 83, 54.2%), representing 6.7% of the original study cohort (n = 1232). Distal aneurysmal diameter progression occurred more frequently after conventional ET or FET procedures (n = 74) than in patients without ET (n = 9) (6.0% vs 0.7%), suggesting that extensive aortic disease or some mild descending aortic dilatation most likely had been present at the primary operation of patients treated by ET or FET. However, the significantly higher incidence of diameter progression in FET compared with conventional ET patients was rather unexpected due to the recent theory of positive aortic remodelling [14, 15] .
In the literature, the true incidence of aneurysmal dilatation of the distal aorta after proximal aortic arch surgery is not well defined but has been reported to vary from 5% to 35% of patients with Marfan syndrome, depending upon the extent of previous surgery and the quality of follow-up [16] . The increased wall tension and the pressure rise in the residual aorta after prosthetic replacement of the ascending aorta, as observed by Scharfschwerdt et al. [17] in an in vitro model, may additionally increase the risk of distal aortic dilatation and subsequent surgery. This also seems to apply for the risk of aortic rupture and dissection, both of which occurred most frequently in the descending aortic segment (Table 2 ).
In the absence of a proximal LZ, an open extensive aortic REDO may be the only treatment option. However, primary surgery including ET and FET procedures may prevent open REDO in the downstream aorta by facilitating subsequent endovascular repair [8, 13, 18, 19] (Fig. 4) . As an alternative to ET/FET procedures, a proximal move of supra-aortic arteries to the ascending aorta can, during conventional arch surgery, sufficiently create an appropriate LZ [12, 20] . This strategy of creating a sufficient LZ during primary arch surgery is also supported by the finding that TEVAR showed a trend towards better survival rates when compared with open REDO of the descending aorta. However, if the respective aortic pathology (e.g. descending aortic aneurysm) extends to the distal level of the descending aorta, the stent graft of the FET prosthesis usually cannot be properly anchored. In such cases, the use of longer hybrid prostheses or TEVAR extension in the same session may be required; however, there is an increased risk of paraplegia [13, 21] .
In the univariate analysis, primary arch replacement with FET was identified as a predictor of increased operative mortality. It remains unclear, however, whether FET is most frequently used in high-risk patients with extensive arch and descending pathology, especially because in some centres, this technique seems to be used preferably or even exclusively in all patients [1] . On the other hand, it is a fact that the use of the FET technique is associated with a longer circulatory arrest time that, undoubtedly, can impact surgical outcome. Nevertheless, a lack of proximal LZ after arch replacement can hinder a later use of TEVAR and can make a more risky and extended open surgery necessary. Therefore, the approach to the primary arch replacement should definitely consider the preparation of a sufficient LZ for potential reinterventions.
Older age at REDO was found to be the only independent risk factor for operative mortality by multivariate analysis. As a matter of fact, surgery in the elderly is often compromised by associated comorbidities, resulting in higher mortality rates [22] . Shortly after primary surgery, the disease process as such may have already strained the body's resources and, as found in the study group, early REDO may be required emergently due to lethal events, such as aortic infection or rupture.
The most evident neurological complication after open and endovascular REDO was paraplegia with an overall occurrence of 6%. These observations stress the need for further measures to completely eliminate paraplegia as the most devastating complication of thoracic and thoraco-abdominal aortic surgery. As there is still no consensus as to whether to reimplant or sacrifice the aortic segmental arteries during open thoracic surgery and thoraco-abdominal surgery. In TEVAR segmental artery preservation is not possible at all, new concepts such as spinal cord collateral network preconditioning by segmental artery occlusion prior to either open or endovascular aortic repair should be considered in the future [23] . However, this new strategy of spinal cord precondition requires further experimental and clinical evaluation [24, 25] .
Limitations
Due to the retrospective nature of the study and the heterogeneity of the study cohort, as regards the different participating centres and the primary surgical indications and techniques of total arch repair performed, the underlying results and their implications may be limited. However, to our knowledge, this retrospective clinical multicentre analysis currently comprises the largest cohort of patients suffering from AEs after primary elective total aortic arch replacement and may therefore offer valuable information to the cardiovascular community.
CONCLUSIONS
In summary, the presented data reveal that the rate of AEs and REDO after elective surgery is not irrelevant and mainly involves the descending aorta. Open and endovascular reoperations have acceptable outcome. However, TEVAR seems beneficial for survival at the descending level, and, consequently, preparation of an adequate proximal LZ at the time of primary arch surgery is advisable. Moreover, routine follow-up and institutional surveillance programmes are necessary after aortic arch surgery for early recognition of pathological sequelae and consequently, the need for reoperation.
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